The National Institutes of Health (NIH) on September 30 announced 52 highly competitive awards for high-risk, high-payoff research for young biomedical scientists, and UCSF tops California institutions with four recipients.
September 29, 2010
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
September 24, 2010
Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.
September 24, 2010
Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.
September 21, 2010
Cancer and infertility can be a double blow. Many women become infertile following cancer treatment. And because more women are living longer thanks to modern chemotherapy and radiation treatment, more are later discovering that they cannot bear children.
September 10, 2010
Nobel laureate Elizabeth Blackburn, president of the American Association for Cancer Research, will deliver a prime time pitch for Stand Up To Cancer to raise funds for groundbreaking translational research that can get new therapies to patients quickly and save lives.
September 07, 2010
UCSF is launching a Facebook fan page and a page focusing on the upcoming “Stand Up to Cancer” national telecast on September 10 to raise the visibility of the health sciences university.
August 25, 2010
UCSF Chancellor Sue Desmond-Hellmann delivers a video message to the UCSF community to mark her first anniversary at the helm of the University.
August 16, 2010
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
August 09, 2010
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML.